A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Neonc Technologies, Inc.
Wake Forest University Health Sciences
NRG Oncology
Mayo Clinic
St. Jude Children's Research Hospital
AC Camargo Cancer Center
University of California, San Francisco
Chinese PLA General Hospital
Stanford University